Evidence map›Paper›PMID 21626402›Full record

ArticleCellular oncology (Dordrecht, Netherlands)2011

Dual effects of β3 integrin subunit expression on human pancreatic cancer models.

S Marchán, S Pérez-Torras, A Vidal, J Adan, F Mitjans, N Carbó, A Mazo

Abstract read
In one paragraph

Article in Cellular oncology (Dordrecht, Netherlands), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

S MarchánDepartament de Bioquímica i Biologia Molecular, Institut de Biomedicina de la UB, Universitat de Barcelona, Spain.
S Pérez-Torras
A Vidal
J Adan
F Mitjans
N Carbó
A Mazo

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPancreatic cancer, the fifth leading cause of adult cancer death in Western countries, lacks early detection, and displays significant dissemination ability. Accumulating evidence shows that integrin-mediated cell attachment to the extracellular matrix induces phenotypes and signaling pathways that regulate tumor cell growth and migration.

methodsIn view of these findings, we examined the role of β(3) in pancreatic cancer by generating two stable β(3)-expressing pancreatic human cell lines and characterizing their behavior in vitro and in vivo.

resultsTransduction of β(3) selectively augmented the functional membrane α(v)β(3) integrin levels, as evident from the enhanced adhesion and migration abilities related to active Rho GTPases. No effects on in vitro anchorage-dependent growth, but higher anoikis were detected in β(3)-overexpressing cells. Moreover, tumors expressing β(3) displayed reduced growth. Interestingly, treatment of mice with an α(v)-blocking antibody inhibited the growth of β(3)-expressing tumors to a higher extent.

conclusionsOur results collectively support the hypothesis that α(v)β(3) integrin has dual actions depending on the cell environment, and provide additional evidence on the role of integrins in pancreatic cancer, which should eventually aid in improving prediction of the effects of therapies addressed to modulate integrin activities in these tumors.

Indexed as

Xenograft Model Antitumor AssaysAnimalsAntibodiesApoptosisCell AdhesionCell CycleCell Line, TumorCell MembraneCell MovementCell ProliferationCell ShapeCell SizeHumansIntegrin beta3MicePancreatic NeoplasmsAntibodiesIntegrin beta3ITGB3 protein, humanProtein Subunitsrho GTP-Binding Proteins

Identifiers

PMID21626402
PMCPMC12994986

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.